(Photo courtesy of CHOP)
The two institutions had already connected for a year-long pilot application of Blackfynn’s data analytics platform for neuroscience research. That period has now been extended to an indeterminate amount of time.
According to the renewed agreement, the system will also be used by both CHOP and the Children’s Brain Tumor Tissue Consortium (CBTTC) to “bring together complex non-identifiable patient data for collaboration and analysis” for pediatric brain cancer research.
Though founder Amanda Christini declined to comment on the financial detail she did say the partnership now allows for an expanded use of the platform, including multiple vertients of data.
“We are thrilled to expand our relationship with CHOP, whose commitment to enabling translational research through collaboration and data access inspires us every day,” said Christini in a press release. “We share their core belief that transformational discovery will only occur when experts can effectively use the vast amounts of disparate, complex data generated in research. Blackfynn’s Data Platform will fundamentally enable this goal.”-30-
Patient transportation startup Roundtrip gets a new partnership amid year of growth
Microsoft, The Meet Group partner on ‘grooming detection technique’ for messaging apps
Digital health company Tridiuum’s CEO on its pivot to product and reducing suicide rates
How the history of Linode HQ inspires its employees
Science Center is launching a telecoms education program for teens in 2020
When a health condition threatens your tech career
Here’s a closer look at Nerd Street Gamers’ deal with Five Below
When it comes to diversity, Vanguard puts its money where its mouth is
Sign-up for daily news updates from Technical.ly Philadelphia